SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Recent SITC data on CAN-2409s immune activation and biodistribution, alongside encouraging updates across Candels lung and glioblastoma programs, has renewed pipeline discussion. Bulls view the prostate-cancer Phase 3 results and planned Q4 BLA as the key value driver; skeptics question the filing timeline, financing needs, and managements communication, and caution that biomarker findings are not proof of clinical benefit.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLAs better-than-expected quarterly results and stronger outlook are driving attention, with traders pointing to AI-related chipmaking demand and equipment spending as support. The reaction is broadly bullish, though some remain cautious after the sharp semiconductor-equipment selloff and debate whether elevated expectations and capex-cycle risks are already priced in.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys sharp rally is centered on its multiyear agreement with AST SpaceMobile to supply rocket engines, license propulsion technology, and provide engineering support for ASTs planned heavy-lift rocket. Traders view the deal as validation and a boost to Fireflys business, while some question the cash-and-stock terms, possible dilution, and execution risks ahead of earnings.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Anticipation of Anthropics potential IPO and its expected effect on DXYZs portfolio value is driving attention, with traders debating whether the listing and updated NAV could lift the fund. Bullish investors see DXYZ as an AI pre-IPO proxy, while skeptics point to IPO-timing uncertainty, valuation risks, and the stocks weak response to related news.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. The firm also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment includes products and services sold for applications within the data center, communication networks and commercial and industrial markets in North America and Latin America. The Asia Pacific segment consists of products and services sold for applications within the data center, communication networks and commercial and industrial markets throughout Greater China, Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Westerville, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertivs strong quarterly results, more than doubled organic orders, and raised outlook are driving attention, reinforcing expectations for demand in AI data-center power and cooling infrastructure. Many traders see the report as evidence the buildout remains strong, while others caution about valuation, the sharp post-earnings move, and whether project spending will persist.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ousters Q3 results, record sensor shipments and outlook for continued growth are driving attention, alongside optimism about demand for its lidar and camera systems in robotics and Physical AI. Traders are weighing that growth story against concerns about margins, valuation and volatility in AI-linked stocks.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

MAGS is drawing attention amid shifting leadership between the Magnificent Seven and semiconductor/AI-infrastructure stocks, with traders debating whether mega-cap tech is stabilizing or still vulnerable. Bearish concerns focus on heavy AI spending and uncertain returns, while others view the pullback and rotation as a chance for the mega-caps to regain leadership.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is under pressure amid concerns that AI-agent upsells may not translate into durable growth: traders question whether customers will pay more for add-ons while cutting seats, and whether discounted multi-year renewals signal weaker pricing power. The debate centers on whether Agentforce can prove value at renewal or whether AI-driven efficiency and software-budget scrutiny will weigh on Salesforces seat-based business.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreed sale of its prenatal testing business to Labcorp for cash is driving attention, with traders pointing to the proceeds as a balance-sheet boost and catalyst for its oncology focus. Bulls cite the strong gap and volume, while skeptics argue the divestiture removes revenue from an already challenged business and leaves debt and execution risks unresolved.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novos Q3 beat and raised outlook, driven by strong demand for the Wegovy pill, are the main catalyst, with traders viewing oral obesity treatments and international expansion as potential growth drivers. The reaction is divided: some see evidence of a recovery, while others question whether Novo can sustain momentum against Lilly and overcome lingering execution concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
